Furthermore, When GOLM1 is downregulated or eliminated by the p-Smad inhibitor SB431542, it promotes EMT in PCa by modulating TGF-β1/Smad2 signaling, but TGF-β1 can then reverse this effect. Here, SMAD2 is linked to posterior cortical atrophy.